Table 2.

AML—induction therapy—3 days of anthracycline and 7 days of cytarabine (“3+7”).

Complete Remission (CR) Rate
SWOG 55–60%
ECOG 65–70%
CALGB 70–75%
MRC 75–85%

CALGB, the Cancer and Leukemia Group B; ECOG, Eastern Cooperative Oncology Group; MRC, Medical Research Council; SWOG, Southwest Oncology Group.

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2013 January; 4(1): e0004. ISSN: 2076-9172
Published online 2013 January 30. doi: 10.5041/RMMJ.10104
Copyright: © 2013 Jacob M. Rowe.